Predictive factors for the progression of diabetic macular ischemia

American Journal of Ophthalmology

Volumn 156, Issue 4, 2013, Pages

  Sim, Dawn A ^a,b   Keane, Pearse A ^a,b   Zarranz Ventura, Javier ^a   Bunce, Catey V ^a,b   Fruttiger, Marcus ^b   Patel, Praveen J ^a,b   Tufail, Adnan ^a,b   Egan, Catherine A ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC MACULAR ISCHEMIA; DISEASE COURSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETINA FOVEA; RETINA ISCHEMIA; RETROSPECTIVE STUDY; VISUAL ACUITY;

EID: 84884586931     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.05.033     Document Type: Article

References (32)

1. G.H. Bresnick, R. Condit, S. Syrjala, M. Palta, A. Groo, and K. Korth Abnormalities of the foveal avascular zone in diabetic retinopathy Arch Ophthalmol 102 9 1984 1286 1293 (Pubitemid 14071827)
2. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group Ophthalmology 98 5 Suppl 1991 807 822
3. A.M. Mansour, A. Schachat, G. Bodiford, and R. Haymond Foveal avascular zone in diabetes mellitus Retina 13 2 1993 125 128 (Pubitemid 23177776)
4. R. Varma, M. Torres, F. Pena, R. Klein, and S.P. Azen Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study Ophthalmology 111 7 2004 1298 1306 (Pubitemid 38844824)
5. T.Y. Wong, R. Klein, and F.M. Islam Diabetic retinopathy in a multi-ethnic cohort in the United States Am J Ophthalmol 141 3 2006 446 455
6. R. Klein, B.E. Klein, S.E. Moss, and K.L. Linton The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus Ophthalmology 99 1 1992 58 62
7. P. Mitchell, F. Bandello, and U. Schmidt-Erfurth The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema Ophthalmology 118 4 2011 615 625
8. Q.D. Nguyen, D.M. Brown, and D.M. Marcus Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE Ophthalmology 119 4 2012 789 801
9. Diabetic Retinopathy Clinical Research Network, M.J. Elman, and H. Qin Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results Ophthalmology 119 11 2012 2312 2318
10. D. Kook, A. Wolf, and T. Kreutzer Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema Retina 28 8 2008 1053 1060
11. E.J. Chung, M.I. Roh, O.W. Kwon, and H.J. Koh Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema Retina 28 7 2008 957 963
12. J.B. Jonas, P. Martus, R.F. Degenring, I. Kreissig, and I. Akkoyun Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema Arch Ophthalmol 123 10 2005 1338 1343 (Pubitemid 41429733)
13. A.S. Neubauer, D. Kook, and C. Haritoglou Bevacizumab and retinal ischemia Ophthalmology 114 11 2007 2096
14. C.S. Lee, and H.J. Koh Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin) with pars plana vitrectomy Acta Ophthalmol 86 2 2008 812 813
15. L.J. Wong, R.U. Desai, and A. Jain Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease Retina 28 8 2008 1151 1158
16. A.A. Rouvas, T.D. Papakostas, I.D. Ladas, and I. Vergados Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation Graefes Arch Clin Exp Ophthalmol 246 2 2008 315 318 (Pubitemid 351149638)
17. M. Michaelides, S. Fraser-Bell, and R. Hamilton Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1 Retina 30 5 2010 781 786
18. P.A. Campochiaro, R.B. Bhisitkul, H. Shapiro, and R.G. Rubio Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion Ophthalmology 120 4 2013 795 802
19. D.A. Sim, P.A. Keane, and J. Zarranz-Ventura The effects of macular ischemia on visual acuity in diabetic retinopathy Invest Ophthalmol Vis Sci 54 4 2013 2353 2360
20. S. Mackenzie, C. Schmermer, and A. Charnley SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme PLoS One 6 5 2011 e14811
21. S.R. Sadda, S. Liakopoulos, and P.A. Keane Relationship between angiographic and optical coherence tomographic (OCT) parameters for quantifying choroidal neovascular lesions Graefes Arch Clin Exp Ophthalmol 248 2 2010 175 184
22. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group Arch Ophthalmol 113 9 1995 1144 1155
23. O. Arend, S. Wolf, and F. Jung Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network Br J Ophthalmol 75 9 1991 514 518
24. J. Conrath, R. Giorgi, D. Raccah, and B. Ridings Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment Eye (Lond) 19 3 2005 322 326 (Pubitemid 40484828)
25. J. Tam, K.P. Dhamdhere, and P. Tiruveedhula Disruption of the retinal parafoveal capillary network in type 2 diabetes before the onset of diabetic retinopathy Invest Ophthalmol Vis Sci 52 12 2011 9257 9266
26. B. Sander, M. Larsen, C. Engler, H. Lund-Andersen, and H.H. Parving Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control Acta Ophthalmol (Copenh) 72 5 1994 553 559 (Pubitemid 24370763)
27. G. Hilmantel, R.A. Applegate, W.A. van Heuven, S.P. Stowers, A. Bradley, and B.L. Lee Entoptic foveal avascular zone measurement and diabetic retinopathy Optom Vis Sci 76 12 1999 826 831
28. H.W. van Dijk, F.D. Verbraak, and P.H. Kok Early neurodegeneration in the retina of type 2 diabetic patients Invest Ophthalmol Vis Sci 53 7 2012 2715 2719
29. L.P. Aiello, and J.S. Wong Role of vascular endothelial growth factor in diabetic vascular complications Kidney Int Suppl 77 2000 S113 S119
30. U. Ticho, and A. Patz The role of capillary perfusion in the management of diabetic macular edema Am J Ophthalmol 76 6 1973 880 886
31. Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early Treatment Diabetic Retinopathy Study Research Group Ophthalmology 98 5 Suppl 1991 834 840
32. B. Hussain, G.M. Saleh, S. Sivaprasad, and C.J. Hammond Changing from Snellen to LogMAR: debate or delay? Clin Experiment Ophthalmol 34 1 2006 6 8 (Pubitemid 43379363)